Sign in with Google. Opens in new tab
bullish
Max Healthcare (MAXHEALTH IN): Robust Financial Performance in Q2; Expansion Projects Are On Track
Tina has highlighted this Insight as a Top Pick
505 Views16 Nov 2023 09:43
SUMMARY
- In Q2FY24, Max Healthcare Institute (MAXHEALT IN) reported revenue growth of 17% YoY and 6% QoQ to INR18.3B, driven by higher ARPOB and occupied bed days.
- EBITDA grew 21% YoY and 14% QoQ to INR4.5B, leading to a 100 basis point YoY and 190 basis point QoQ margin expansion to 28.7%.
- MHIL expect greenfield 300 bed hospital in Dwarka, South-west Delhi will be commissioned in later half of Q4FY24. It was originally expected to be commissioned in Q2FY24.
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- [Japan Buybacks] - Japan Bank Metrics, Cross-Holdings and Banks Part 1
- NTT DC REIT IPO: Global Index Inclusions Later This Year + A Kicker
- Samsung Electronics: Share Buyback of 3.9 Trillion Won
- SICC A/H Listing - Past Growth Has Been Volatile
- Breaking Down the Moving Parts in Samsung’s Third-Leg Buyback Play
Top Unpaywalled Insights
More »Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Max Healthcare (MAXHEALTH IN): Multi-Pronged Expansion Strategy Augurs Well for Sustainable Growth11 Apr 2025
- Max Healthcare (MAXHEALTH IN): Continues to Strengthen Presence in North India16 Sep 2024
- Max Healthcare (MAXHEALTH IN): New Hospital Acquisition Expands Footfall in a New Populus City10 Dec 2023
- Max Healthcare (MAXHEALTH IN): Robust Financial Performance in Q2; Expansion Projects Are On Track16 Nov 2023
- Max Healthcare (MAXHEALTH IN): Record High Sales and Profitability in Q4; Expansion to Drive Growth18 Jul 2023
- Max Healthcare (MAXHEALTH IN): Improving Operating Parameters; Well-Positioned for Long-Term Growth17 Apr 2023
- Max Healthcare (MAXHEALTH IN): 4QFY22 Review- Continued Growth Momentum; Better Profitability30 Jun 2022
x